[go: up one dir, main page]

DK0764172T3 - Syntetiske peptidanaloger af lungeoverfladeproteinet SP-C - Google Patents

Syntetiske peptidanaloger af lungeoverfladeproteinet SP-C

Info

Publication number
DK0764172T3
DK0764172T3 DK95920906T DK95920906T DK0764172T3 DK 0764172 T3 DK0764172 T3 DK 0764172T3 DK 95920906 T DK95920906 T DK 95920906T DK 95920906 T DK95920906 T DK 95920906T DK 0764172 T3 DK0764172 T3 DK 0764172T3
Authority
DK
Denmark
Prior art keywords
pct
image
synthetic peptide
surface protein
peptide analogues
Prior art date
Application number
DK95920906T
Other languages
Danish (da)
English (en)
Inventor
Ruediger Nave
Wolf-Ruediger Ulrich
Ernst Sturm
Dietrich Haefner
Klaus P Schaefer
Uwe Krueger
Klaus Melchers
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6519392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0764172(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK0764172T3 publication Critical patent/DK0764172T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95920906T 1994-05-31 1995-05-27 Syntetiske peptidanaloger af lungeoverfladeproteinet SP-C DK0764172T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4418936A DE4418936A1 (de) 1994-05-31 1994-05-31 Polypeptid
PCT/EP1995/002028 WO1995032992A1 (fr) 1994-05-31 1995-05-27 Analogues peptidiques de synthese de la proteine sp-c de surfactant

Publications (1)

Publication Number Publication Date
DK0764172T3 true DK0764172T3 (da) 2005-01-10

Family

ID=6519392

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95920906T DK0764172T3 (da) 1994-05-31 1995-05-27 Syntetiske peptidanaloger af lungeoverfladeproteinet SP-C

Country Status (29)

Country Link
US (1) US5874406A (fr)
EP (1) EP0764172B1 (fr)
JP (1) JP3359638B2 (fr)
KR (1) KR100355626B1 (fr)
CN (1) CN1130374C (fr)
AT (1) ATE275154T1 (fr)
AU (1) AU690280B2 (fr)
BG (1) BG63210B1 (fr)
BR (1) BR9507811B1 (fr)
CA (1) CA2191344C (fr)
CY (1) CY2552B1 (fr)
CZ (1) CZ286976B6 (fr)
DE (2) DE4418936A1 (fr)
DK (1) DK0764172T3 (fr)
EE (1) EE03775B1 (fr)
ES (1) ES2227548T3 (fr)
FI (1) FI118126B (fr)
HK (1) HK1000891A1 (fr)
HU (1) HU220191B (fr)
NO (1) NO317149B1 (fr)
NZ (1) NZ287447A (fr)
PL (1) PL181234B1 (fr)
PT (1) PT764172E (fr)
RO (1) RO118752B1 (fr)
RU (1) RU2145611C1 (fr)
SI (1) SI0764172T1 (fr)
SK (1) SK282441B6 (fr)
UA (1) UA35636C2 (fr)
WO (1) WO1995032992A1 (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2322097A (en) * 1996-03-27 1997-10-17 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
DE19851119C2 (de) 1998-11-06 2001-05-31 Byk Gulden Lomberg Chem Fab Behälter und Vorrichtung zur Blindung der Verabreichung von nicht festen pharmazeutischen Darreichungsformen bei der klinischen Prüfung
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
AU5400000A (en) * 1999-06-11 2001-01-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
ES2278609T3 (es) 1999-06-17 2007-08-16 Altana Pharma Ag Esteres tensioactivos de la proteina c.
US7053176B1 (en) 1999-09-16 2006-05-30 Altana Pharma Ag Combination of C1-INH and lung surfactant for the treatment of respiratory disorders
WO2001039573A2 (fr) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Utilisation nouvelle d'agent tensio-actif du poumon
WO2001058423A1 (fr) * 2000-02-11 2001-08-16 Altana Pharma Ag Nouvelle utilisation d'un surfactant pulmonaire dans la prophylaxie et le traitement des maladies pulmonaires chroniques
US6660833B1 (en) * 2000-02-29 2003-12-09 Harbor-Ucla Research And Education Institute Respiratory distress syndrome therapy with peptide analogs of human SP-B
DK1276495T3 (da) * 2000-04-12 2006-08-14 Altana Pharma Ag Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
RU2161501C1 (ru) * 2000-06-29 2001-01-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Способ получения пептидов, обладающих тканеспецифической активностью, и фармацевтические композиции на их основе
ATE468131T1 (de) 2001-10-11 2010-06-15 Nycomed Gmbh Neue verwendung von lungensurfactant
WO2003053455A1 (fr) 2001-12-12 2003-07-03 Penn State Research Foundation Surfactants destines au traitement de la fibrose pulmonaire
CA2575513C (fr) * 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprenant un tensioactif pulmonaire et un peptide derive de tnf
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
SI1841458T1 (sl) 2005-01-06 2012-04-30 Discovery Lab Inc Zdravljenje s predpisanim odmerjanjem surfaktanta za zdravljenje ali preprečevanje bronhopulmonalne displazije
DE102005014650B3 (de) * 2005-03-31 2006-08-17 Altana Pharma Ag Anordnung aus Katheter und Anschlussstück sowie Ventil zum Durchführen eines Katheters
DE102005016229B3 (de) 2005-04-08 2006-06-14 Altana Pharma Ag Trockenvernebler
ZA200902487B (en) * 2006-09-19 2010-07-28 Discovery Lab Inc Pulmonary surfactant formulations and methods for promoting mucus clearance
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
EP2009023A1 (fr) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Nouveaux peptides et leur utilisation pour le traitement de l'oedème
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
WO2010068754A2 (fr) 2008-12-10 2010-06-17 Paka Pulmonary Pharmaceuticals, Inc. Procédés et compositions pour la délivrance de médicaments aux poumons
BR112012004651B1 (pt) 2009-09-08 2022-02-08 Chiesi Farmaceutici S.P.A. Surfactante pulmonar exógeno, uso de uma combinação terapêutica, medicamento e kit
RU2415676C1 (ru) * 2009-12-09 2011-04-10 Общество С Ограниченной Ответственностью "Гармония" Способ получения средства, обладающего тканеспецифической активностью, и средство, полученное данным способом (варианты)
MX2013001936A (es) 2010-08-23 2013-03-08 Takeda Gmbh Particulas humidificadas que comprenden una sustancia terapeuticamente activa.
EP2812018B1 (fr) * 2012-02-09 2018-12-05 University Of Rochester Nouveaux peptides sp-b et sp-c, tensioactifs pulmonaires synthétiques, et leurs utilisations
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
WO2013188016A2 (fr) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Thérapie utilisant des surfactants pour exposition à un rayonnement ionisant
JP6803002B2 (ja) 2014-03-05 2020-12-23 フラウンホファー ゲセルシャフト ツール フェールデルンク ダー アンゲヴァンテン フォルシュンク エー．ファオ． エーロゾルを加湿する加湿機
EP3106090A1 (fr) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. Système pour une administration efficace, synchronisée avec la respiration, d'un médicament aux poumons
EP3285645B1 (fr) 2015-04-22 2020-08-12 Chiesi Farmaceutici S.p.A. Système pour une administration efficace, synchronisée avec la respiration, d'un médicament aux poumons
WO2016173634A1 (fr) 2015-04-28 2016-11-03 Chiesi Farmaceutici S.P.A Dispositif permettant de faciliter l'administration d'un médicament aux poumons par l'intermédiaire d'un cathéter
US20180147262A1 (en) * 2015-04-30 2018-05-31 University Of Bremen Novel skin medical and cosmetic care product
WO2018019719A1 (fr) 2016-07-28 2018-02-01 Chiesi Farmaceutici S.P.A Procédé et système d'administration d'un médicament sous forme d'aérosol
WO2018077623A1 (fr) 2016-10-26 2018-05-03 Chiesi Farmaceutici S.P.A. Dispositif permettant de faciliter l'administration d'un médicament aux poumons par l'intermédiaire d'un cathéter
AU2017384467B2 (en) 2016-12-22 2023-10-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving BPD
CN107163148A (zh) * 2017-05-15 2017-09-15 重庆理工大学 肺表面活性蛋白b前肽的重组蛋白及其制备方法和应用
WO2019115771A1 (fr) 2017-12-15 2019-06-20 Pari Pharma Gmbh Système de nébuliseur, système de maintien, combinaison comprenant un système de nébuliseur et un système de maintien, et procédé d'administration d'aérosol
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
MA52353A (fr) 2018-04-23 2021-04-28 Chiesi Farm Spa Combinaison thérapeutique comprenant un tensioactif pulmonaire et un stéroïde pour la prophylaxie de la dbp
CN109001466A (zh) * 2018-07-19 2018-12-14 新疆维吾尔自治区人民医院 一种用于osa的肺表面活性蛋白试剂盒及其应用
EP3666316A1 (fr) 2018-12-14 2020-06-17 PARI Pharma GmbH Dispositif d'administration d'aérosol et procédé pour faire fonctionner un dispositif d'administration d'aérosol
EP3666315A1 (fr) 2018-12-14 2020-06-17 PARI Pharma GmbH Dispositif d'administration d'aérosol et procédé de fonctionnement du dispositif d'administration d'aérosol
EP3843105A1 (fr) 2019-12-23 2021-06-30 PARI Pharma GmbH Dispositif de commande pour système nébuliseur d'aérosol
US20230257446A1 (en) 2020-01-28 2023-08-17 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
EP4411745A1 (fr) 2023-02-01 2024-08-07 Pari Medical Holding GmbH Procédé d'évaluation médicale, nébuliseur d'aérosol et système d'évaluation médicale
EP4464236A1 (fr) 2023-05-15 2024-11-20 Pari Medical Holding GmbH Procédé de fonctionnement d'un dispositif d'inhalation, dispositif d'inhalation et système de dispositif d'inhalation pour fournir une rétroaction de processus d'inhalation
EP4464354A1 (fr) 2023-05-15 2024-11-20 Pari Medical Holding GmbH Procédé de fonctionnement d'un dispositif d'inhalation, dispositif d'inhalation et système de dispositif d'inhalation pour fournir un processus d'inhalation/guidage de respiration

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
US5169761A (en) * 1984-12-11 1992-12-08 California Biotechnology Inc. Dna encoding and expression systems for alveolar surfactant proteins
US4933280A (en) * 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
JP2602968B2 (ja) * 1987-11-04 1997-04-23 カリフォルニア バイオテクノロジー インコーポレイテッド 肺胞の界面活性タンパク類
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤

Also Published As

Publication number Publication date
CA2191344A1 (fr) 1995-12-07
CY2552B1 (en) 2008-07-02
DE4418936A1 (de) 1996-02-08
KR970703367A (ko) 1997-07-03
NO317149B1 (no) 2004-08-30
PL317420A1 (en) 1997-04-14
AU2616995A (en) 1995-12-21
RO118752B1 (ro) 2003-10-30
BR9507811A (pt) 1997-09-16
CN1130374C (zh) 2003-12-10
EP0764172B1 (fr) 2004-09-01
ES2227548T3 (es) 2005-04-01
CN1154117A (zh) 1997-07-09
HU220191B (hu) 2001-11-28
RU2145611C1 (ru) 2000-02-20
NZ287447A (en) 1998-01-26
SK152496A3 (en) 1997-06-04
US5874406A (en) 1999-02-23
PL181234B1 (pl) 2001-06-29
NO965052L (no) 1997-01-28
CA2191344C (fr) 2003-04-08
CZ286976B6 (en) 2000-08-16
EP0764172A1 (fr) 1997-03-26
MX9605986A (es) 1998-06-30
BR9507811B1 (pt) 2009-05-05
JPH10504025A (ja) 1998-04-14
DE59510941D1 (de) 2004-10-07
EE03775B1 (et) 2002-06-17
HU9603249D0 (en) 1997-01-28
SK282441B6 (sk) 2002-02-05
HK1000891A1 (en) 2004-09-17
PT764172E (pt) 2005-01-31
SI0764172T1 (en) 2005-02-28
KR100355626B1 (ko) 2002-12-26
CZ350296A3 (en) 1997-05-14
BG101028A (en) 1998-01-30
JP3359638B2 (ja) 2002-12-24
UA35636C2 (uk) 2001-04-16
EE9600175A (et) 1997-06-16
FI118126B (fi) 2007-07-13
AU690280B2 (en) 1998-04-23
WO1995032992A1 (fr) 1995-12-07
BG63210B1 (bg) 2001-06-29
ATE275154T1 (de) 2004-09-15
NO965052D0 (no) 1996-11-27
FI964766A0 (fi) 1996-11-29
HUT76952A (hu) 1998-01-28
FI964766A7 (fi) 1996-11-29

Similar Documents

Publication Publication Date Title
DK0764172T3 (da) Syntetiske peptidanaloger af lungeoverfladeproteinet SP-C
BG105764A (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
FI895382A0 (fi) Uretan-skyddade aminosyra-n -karboxianhydrider.
ATE199730T1 (de) Oberflächenaktives lungenprotein und verwandte polypeptide
FI916077A7 (fi) Glykosyloimattomia ihmisen interleukiini 3:n proteiinianalogeja
TR199501630A2 (tr) Peptid p277 benzerleri ve diagnoz ve dibetlerin'lerin tedavisi icin onlari iceren kompozisyonlar.
ES548052A0 (es) Procedimiento para preparar peptidos
EP0796867A4 (fr) Peptide, bronchodilatateur et agent facilitant l'ecoulement sanguin
ATE42308T1 (de) Pharmakologisch aktive peptide.
GR3001922T3 (en) Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration
ATE92078T1 (de) Pharmakologisch aktive peptide.
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
EP0374089A3 (fr) Utilisation de dérivés de la somatostatine comme agents protecteurs des poumons
JPS649938A (en) Oral ingestive composition
AU7052191A (en) Antitumoral composition based on polypeptides having human interleukin 2 activity
SE9000793D0 (sv) Sdk-peptider,foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem
PT99850A (pt) Processo para a preparacao de novos peptideos com efeito insulinico
DK128091A (da) Kloning og fremstilling af polypeptidanaloger af humant fibronektin og anvendelse af saadanne polypeptidanaloger
AU7627987A (en) Use of 2-aminoalkyl-5-pyridinols as nootropic agents and anti-depressants
ATE82504T1 (de) Herrichtung und verwendung eines physiologisch aktiven polypeptids zur aids-therapie.